Company Ticker News March 1, 2022AbbVie closes deal to buy Syndesi Therapeutics for up to $1 billion 0 0 Share
Company Ticker News March 1, 2022AbbVie to Present at the Cowen 42nd Annual Health Care Conference 0 0 Share
Company Ticker News March 1, 2022AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio 0 0 Share
Press Release February 28, 2022AbbVie Seeks New Indication for IMBRUVICA® (ibrutinib) in Pediatric Patients with Chronic Graft Versus Host Disease (cGVHD) 0 0 Share
Company Ticker News February 28, 2022Investing Club: We're capitalizing on one of our drug stocks' incredible run, selling some shares 0 0 Share
Company Ticker News February 27, 2022These 5 Stocks Will Make Me More Than $3,000 in Passive Income This Year 0 0 Share
Press Release February 22, 2022AbbVie Submits Supplemental New Drug Application to U.S. FDA for cariprazine (VRAYLAR®) for the Adjunctive Treatment of Major Depressive Disorder 0 0 Share
